Fox Run Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$670K Buy
+10,778
New +$760K 0.12% 315
2025
Q4
Sell
-12,312
Closed -$903K 1042
2025
Q3
$903K Sell
12,312
-3,910
-24% -$260K 0.14% 249
2025
Q2
$844K Buy
+16,222
New +$923K 0.14% 248
2025
Q1
Sell
-10,224
Closed -$489K 1029
2024
Q4
$489K Buy
+10,224
New +$524K 0.09% 442
2024
Q3
Sell
-5,001
Closed -$262K 926
2024
Q2
$262K Sell
5,001
-11,848
-70% -$520K 0.05% 584
2024
Q1
$685K Buy
+16,849
New +$632K 0.15% 264
2023
Q4
Sell
-17,510
Closed -$669K 835
2023
Q3
$669K Buy
+17,510
New +$717K 0.2% 172
2022
Q3
Sell
-7,639
Closed -$336K 701
2022
Q2
$336K Buy
+7,639
New +$330K 0.17% 254
2019
Q1
Sell
-10,313
Closed -$151K 562
2018
Q4
$151K Sell
10,313
-7,652
-43% -$122K 0.08% 442
2018
Q3
$326K Buy
+17,965
New +$315K 0.14% 323
2018
Q2
Sell
-12,429
Closed -$243K 770
2018
Q1
$243K Sell
12,429
-25,916
-68% -$502K 0.06% 567
2017
Q4
$777K Buy
38,345
+21,445
+127% +$394K 0.23% 125
2017
Q3
$294K Buy
+16,900
New +$229K 0.08% 500

Other funds holding HALO